3 days Ago By ABMN Staff
electroCore, Inc. ( NASDAQ:ECOR – Free Report ) – Analysts at Brookline Capital Management dropped their FY2024 earnings per share estimates for shares of electroCore in a research note issued to investors on Thursday, November 14th. Brookline Capital Management analyst T.
Bussian now anticipates that the company will earn ($1.40) per share for the year, down from their prior estimate of ($1.03).
The consensus estimate for electroCore’s current full-year earnings is ($1.44) per share. Brookline Capital Management also issued estimates for electroCore’s Q4 2024 earnings at ($0.
33) EPS. electroCore Price Performance NASDAQ:ECOR opened at $9.65 on Monday.
electroCore has a 1-year low of $5.02 and a 1-year high of $14.20.
The business has a 50 day moving average of $8.96 and a 200 day moving average of $7.26.
The company has a market capitalization of $63.26 million, a price-to-earnings ratio of -5.27 and a beta of 0.
56. Institutional Investors Weigh In On electroCore About electroCore ( Get Free Report ) electroCore, Inc, a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania.
See Also Receive News & Ratings for electroCore Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for electroCore and related companies with MarketBeat.com's FREE daily email newsletter ..
